| Wissenschaftl. Titel | A randomized, open-label,rater-blinded,active-controlled, international, multicenter study to evaluate the efficacy, safety and tolerability of flexibly dosed Esketamine Nasal Spray compared with Quetiapine Extended-Release in adult and elderly participants with Treatment-resistant Major Depressive Disorder who are continuing a selective Serotonin Reuptake Inhibitor/serotonin-Norepinephrine Reuptake inhibitor |
| Erkrankung |
Psyche:
Affektive Störungen:
Depression
|
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 30.04.2021 Student Studienregister
geändert 18.02.2022 Sina Hehn